好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Siponimod Reduces Neurofilament Light Chain Blood Levels in Secondary Progressive Multiple Sclerosis Patients
Multiple Sclerosis
S8 - (-)
006
Authors/Disclosures
Jens Kuhle, MD
PRESENTER
Dr. Kuhle has nothing to disclose.
Harald Kropshofer Harald Kropshofer has nothing to disclose.
Christian Barro, MD, PhD (Brigham and Women's Hospital) Dr. Barro has nothing to disclose.
No disclosure on file
Dieter Haering Dieter Haering has received personal compensation for serving as an employee of Novartis.
David Leppert, MD (University Hospital Basel) Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Davorka Tomic Davorka Tomic has stock in Meck KGaA.
Frank Dahlke, MD, PhD Dr. Dahlke has received personal compensation for serving as an employee of Novartis.
Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel) Dr. Kappos has nothing to disclose.